Novartis disclosed plans to build another factory in the US as part of its $23 billion expansion commitment, marking the final new build in the program. The company said it has allocated every dollar of the $23 billion promise to expand in the US. The announcement underscores Novartis’ push to add manufacturing capacity ahead of pipeline growth and regulatory demand across global markets.